DossierENTITY

lung-cancer

Coverage of lung-cancer in the Nexus archive.

Earliest in view: Jun 1 · 12:06 UTCMost recent: Jun 1 · 12:06 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 1 · 12:06 UTCMARKETWATCH
An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.
An experimental lung-cancer drug, ivonescimab, showed a 34% reduction in risk of death compared to Keytruda. However, investors remain unimpressed by the results.